nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—Calcipotriol—psoriasis	0.269	0.346	CbGbCtD
Ticlopidine—CYP1A1—Clobetasol propionate—psoriasis	0.0784	0.101	CbGbCtD
Ticlopidine—CYP1A1—Methoxsalen—psoriasis	0.0412	0.0531	CbGbCtD
Ticlopidine—CYP2C8—Tazarotene—psoriasis	0.0369	0.0475	CbGbCtD
Ticlopidine—CYP1A2—Clobetasol propionate—psoriasis	0.035	0.0451	CbGbCtD
Ticlopidine—CYP1A1—Cholecalciferol—psoriasis	0.0273	0.0351	CbGbCtD
Ticlopidine—CYP2B6—Cholecalciferol—psoriasis	0.0208	0.0268	CbGbCtD
Ticlopidine—CYP1A2—Methoxsalen—psoriasis	0.0184	0.0237	CbGbCtD
Ticlopidine—CYP2D6—Hydroxyurea—psoriasis	0.0166	0.0214	CbGbCtD
Ticlopidine—CYP2C8—Cholecalciferol—psoriasis	0.0157	0.0203	CbGbCtD
Ticlopidine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0136	0.0176	CbGbCtD
Ticlopidine—CYP2C19—Cholecalciferol—psoriasis	0.0132	0.017	CbGbCtD
Ticlopidine—CYP3A4—Calcitriol—psoriasis	0.0124	0.016	CbGbCtD
Ticlopidine—CYP1A1—Dexamethasone—psoriasis	0.0118	0.0152	CbGbCtD
Ticlopidine—CYP2C9—Cholecalciferol—psoriasis	0.011	0.0141	CbGbCtD
Ticlopidine—CYP2C8—Hydrocortisone—psoriasis	0.0109	0.0141	CbGbCtD
Ticlopidine—CYP2C8—Cyclosporine—psoriasis	0.0103	0.0133	CbGbCtD
Ticlopidine—CYP2D6—Cholecalciferol—psoriasis	0.01	0.0129	CbGbCtD
Ticlopidine—CYP3A4—Methoxsalen—psoriasis	0.00963	0.0124	CbGbCtD
Ticlopidine—CYP2C19—Prednisone—psoriasis	0.00915	0.0118	CbGbCtD
Ticlopidine—CYP2E1—Dexamethasone—psoriasis	0.00911	0.0117	CbGbCtD
Ticlopidine—CYP2B6—Dexamethasone—psoriasis	0.00899	0.0116	CbGbCtD
Ticlopidine—CYP2C19—Cyclosporine—psoriasis	0.00867	0.0112	CbGbCtD
Ticlopidine—CYP2C9—Cyclosporine—psoriasis	0.00721	0.0093	CbGbCtD
Ticlopidine—CYP2C8—Dexamethasone—psoriasis	0.00681	0.00878	CbGbCtD
Ticlopidine—CYP2D6—Cyclosporine—psoriasis	0.00659	0.0085	CbGbCtD
Ticlopidine—CYP3A4—Cholecalciferol—psoriasis	0.00638	0.00823	CbGbCtD
Ticlopidine—CYP2C19—Dexamethasone—psoriasis	0.00571	0.00736	CbGbCtD
Ticlopidine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00553	0.00713	CbGbCtD
Ticlopidine—CYP3A4—Triamcinolone—psoriasis	0.00553	0.00713	CbGbCtD
Ticlopidine—CYP2C9—Dexamethasone—psoriasis	0.00475	0.00612	CbGbCtD
Ticlopidine—CYP3A4—Betamethasone—psoriasis	0.00475	0.00612	CbGbCtD
Ticlopidine—CYP3A4—Prednisolone—psoriasis	0.00468	0.00604	CbGbCtD
Ticlopidine—CYP3A4—Hydrocortisone—psoriasis	0.00444	0.00572	CbGbCtD
Ticlopidine—CYP3A4—Prednisone—psoriasis	0.00442	0.0057	CbGbCtD
Ticlopidine—CYP2D6—Dexamethasone—psoriasis	0.00434	0.0056	CbGbCtD
Ticlopidine—CYP3A4—Cyclosporine—psoriasis	0.00419	0.00541	CbGbCtD
Ticlopidine—CYP3A4—Dexamethasone—psoriasis	0.00276	0.00356	CbGbCtD
Ticlopidine—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00182	0.0257	CbGpPWpGaD
Ticlopidine—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00163	0.023	CbGpPWpGaD
Ticlopidine—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.0015	0.0211	CbGpPWpGaD
Ticlopidine—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00148	0.0209	CbGpPWpGaD
Ticlopidine—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.0014	0.0197	CbGpPWpGaD
Ticlopidine—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00133	0.0188	CbGpPWpGaD
Ticlopidine—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00131	0.0185	CbGpPWpGaD
Ticlopidine—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.00123	0.0174	CbGpPWpGaD
Ticlopidine—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00113	0.016	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—IL17A—psoriasis	0.00109	0.0154	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—IL12B—psoriasis	0.00101	0.0143	CbGpPWpGaD
Ticlopidine—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00101	0.0142	CbGpPWpGaD
Ticlopidine—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000927	0.0131	CbGpPWpGaD
Ticlopidine—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000919	0.013	CbGpPWpGaD
Ticlopidine—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000786	0.0111	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—HCAR2—psoriasis	0.000697	0.00984	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—SERPINB8—psoriasis	0.000623	0.0088	CbGpPWpGaD
Ticlopidine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000606	0.00856	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—NFKBIA—psoriasis	0.000568	0.00802	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—NOS2—psoriasis	0.000568	0.00802	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000554	0.00783	CbGpPWpGaD
Ticlopidine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000554	0.00782	CbGpPWpGaD
Ticlopidine—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000547	0.00772	CbGpPWpGaD
Ticlopidine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000543	0.00766	CbGpPWpGaD
Ticlopidine—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000536	0.00756	CbGpPWpGaD
Ticlopidine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000512	0.00722	CbGpPWpGaD
Ticlopidine—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000505	0.00713	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—CAT—psoriasis	0.000494	0.00697	CbGpPWpGaD
Ticlopidine—MPO—Vitamin B12 Metabolism—CRP—psoriasis	0.000482	0.00681	CbGpPWpGaD
Ticlopidine—MPO—Vitamin B12 Metabolism—APOE—psoriasis	0.000472	0.00666	CbGpPWpGaD
Ticlopidine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000469	0.00662	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—TYK2—psoriasis	0.000465	0.00657	CbGpPWpGaD
Ticlopidine—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000463	0.00654	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—IL4—psoriasis	0.000454	0.00641	CbGpPWpGaD
Ticlopidine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000449	0.00634	CbGpPWpGaD
Ticlopidine—MPO—Vitamin B12 Metabolism—ICAM1—psoriasis	0.000443	0.00626	CbGpPWpGaD
Ticlopidine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00044	0.00621	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—IFNG—psoriasis	0.000436	0.00615	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—HCAR2—psoriasis	0.000422	0.00596	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—CD4—psoriasis	0.000421	0.00594	CbGpPWpGaD
Ticlopidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000419	0.00591	CbGpPWpGaD
Ticlopidine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000415	0.00586	CbGpPWpGaD
Ticlopidine—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000413	0.00583	CbGpPWpGaD
Ticlopidine—MPO—Selenium Micronutrient Network—CAT—psoriasis	0.000392	0.00554	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—CRP—psoriasis	0.000392	0.00554	CbGpPWpGaD
Ticlopidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000385	0.00544	CbGpPWpGaD
Ticlopidine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000382	0.00539	CbGpPWpGaD
Ticlopidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00038	0.00537	CbGpPWpGaD
Ticlopidine—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00038	0.00537	CbGpPWpGaD
Ticlopidine—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000377	0.00532	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—NFKB1—psoriasis	0.000363	0.00512	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—CCL20—psoriasis	0.000362	0.00511	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—ICAM1—psoriasis	0.00036	0.00509	CbGpPWpGaD
Ticlopidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000339	0.00479	CbGpPWpGaD
Ticlopidine—MPO—Vitamin B12 Metabolism—IFNG—psoriasis	0.000337	0.00476	CbGpPWpGaD
Ticlopidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000326	0.00461	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—STAT3—psoriasis	0.000326	0.0046	CbGpPWpGaD
Ticlopidine—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000322	0.00455	CbGpPWpGaD
Ticlopidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000312	0.00441	CbGpPWpGaD
Ticlopidine—MPO—Selenium Micronutrient Network—CRP—psoriasis	0.000312	0.0044	CbGpPWpGaD
Ticlopidine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00031	0.00437	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000288	0.00406	CbGpPWpGaD
Ticlopidine—MPO—Selenium Micronutrient Network—ICAM1—psoriasis	0.000286	0.00404	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—TNF—psoriasis	0.000282	0.00398	CbGpPWpGaD
Ticlopidine—MPO—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000281	0.00396	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—IFNG—psoriasis	0.000274	0.00387	CbGpPWpGaD
Ticlopidine—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000268	0.00378	CbGpPWpGaD
Ticlopidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000264	0.00373	CbGpPWpGaD
Ticlopidine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000255	0.00359	CbGpPWpGaD
Ticlopidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000252	0.00356	CbGpPWpGaD
Ticlopidine—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.000251	0.00354	CbGpPWpGaD
Ticlopidine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000249	0.00352	CbGpPWpGaD
Ticlopidine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000248	0.00351	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000246	0.00347	CbGpPWpGaD
Ticlopidine—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000239	0.00337	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—HCAR2—psoriasis	0.000239	0.00337	CbGpPWpGaD
Ticlopidine—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000235	0.00332	CbGpPWpGaD
Ticlopidine—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000234	0.0033	CbGpPWpGaD
Ticlopidine—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000231	0.00325	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—NFKB1—psoriasis	0.000228	0.00322	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—IL6—psoriasis	0.000228	0.00321	CbGpPWpGaD
Ticlopidine—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.00022	0.00311	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—CCL20—psoriasis	0.000219	0.0031	CbGpPWpGaD
Ticlopidine—MPO—C-MYB transcription factor network—CD4—psoriasis	0.000218	0.00308	CbGpPWpGaD
Ticlopidine—MPO—Vitamin B12 Metabolism—TNF—psoriasis	0.000218	0.00308	CbGpPWpGaD
Ticlopidine—MPO—Selenium Micronutrient Network—IFNG—psoriasis	0.000218	0.00308	CbGpPWpGaD
Ticlopidine—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000217	0.00307	CbGpPWpGaD
Ticlopidine—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000217	0.00306	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HCAR2—psoriasis	0.000217	0.00306	CbGpPWpGaD
Ticlopidine—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000214	0.00302	CbGpPWpGaD
Ticlopidine—Haemorrhage—Hydrocortisone—psoriasis	0.000207	0.00135	CcSEcCtD
Ticlopidine—Dizziness—Acitretin—psoriasis	0.000206	0.00134	CcSEcCtD
Ticlopidine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000205	0.00134	CcSEcCtD
Ticlopidine—Epistaxis—Triamcinolone—psoriasis	0.000205	0.00134	CcSEcCtD
Ticlopidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000204	0.00288	CbGpPWpGaD
Ticlopidine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000202	0.00285	CbGpPWpGaD
Ticlopidine—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000202	0.00285	CbGpPWpGaD
Ticlopidine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000201	0.00284	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Mycophenolic acid—psoriasis	0.0002	0.00131	CcSEcCtD
Ticlopidine—Flatulence—Cyclosporine—psoriasis	0.0002	0.0013	CcSEcCtD
Ticlopidine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000199	0.00281	CbGpPWpGaD
Ticlopidine—Vomiting—Acitretin—psoriasis	0.000198	0.00129	CcSEcCtD
Ticlopidine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000197	0.00129	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Methotrexate—psoriasis	0.000197	0.00129	CcSEcCtD
Ticlopidine—Rash—Acitretin—psoriasis	0.000196	0.00128	CcSEcCtD
Ticlopidine—Dermatitis—Acitretin—psoriasis	0.000196	0.00128	CcSEcCtD
Ticlopidine—Haemoglobin—Triamcinolone—psoriasis	0.000196	0.00128	CcSEcCtD
Ticlopidine—Rash—Fluocinolone Acetonide—psoriasis	0.000196	0.00128	CcSEcCtD
Ticlopidine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000196	0.00127	CcSEcCtD
Ticlopidine—Anorexia—Mycophenolic acid—psoriasis	0.000195	0.00127	CcSEcCtD
Ticlopidine—Muscle spasms—Cyclosporine—psoriasis	0.000195	0.00127	CcSEcCtD
Ticlopidine—Haemorrhage—Triamcinolone—psoriasis	0.000195	0.00127	CcSEcCtD
Ticlopidine—Flatulence—Mycophenolate mofetil—psoriasis	0.000195	0.00127	CcSEcCtD
Ticlopidine—Headache—Acitretin—psoriasis	0.000195	0.00127	CcSEcCtD
Ticlopidine—Headache—Fluocinolone Acetonide—psoriasis	0.000194	0.00127	CcSEcCtD
Ticlopidine—Abdominal distension—Prednisone—psoriasis	0.000194	0.00126	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Betamethasone—psoriasis	0.000193	0.00126	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Dexamethasone—psoriasis	0.000193	0.00126	CcSEcCtD
Ticlopidine—Body temperature increased—Hydroxyurea—psoriasis	0.000193	0.00126	CcSEcCtD
Ticlopidine—Muscle spasms—Mycophenolate mofetil—psoriasis	0.00019	0.00124	CcSEcCtD
Ticlopidine—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.00019	0.00268	CbGpPWpGaD
Ticlopidine—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000187	0.00122	CcSEcCtD
Ticlopidine—Osteoarthritis—Methotrexate—psoriasis	0.000186	0.00121	CcSEcCtD
Ticlopidine—Angioedema—Cyclosporine—psoriasis	0.000185	0.00121	CcSEcCtD
Ticlopidine—Nausea—Acitretin—psoriasis	0.000185	0.00121	CcSEcCtD
Ticlopidine—Nausea—Fluocinolone Acetonide—psoriasis	0.000184	0.0012	CcSEcCtD
Ticlopidine—MPO—Selenium Micronutrient Network—NFKB1—psoriasis	0.000181	0.00256	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—ITGAL—psoriasis	0.000181	0.00255	CbGpPWpGaD
Ticlopidine—Angioedema—Mycophenolate mofetil—psoriasis	0.000181	0.00118	CcSEcCtD
Ticlopidine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.00018	0.00255	CbGpPWpGaD
Ticlopidine—Dyspepsia—Mycophenolic acid—psoriasis	0.00018	0.00117	CcSEcCtD
Ticlopidine—Hypersensitivity—Hydroxyurea—psoriasis	0.00018	0.00117	CcSEcCtD
Ticlopidine—Decreased appetite—Mycophenolic acid—psoriasis	0.000178	0.00116	CcSEcCtD
Ticlopidine—Haemoglobin—Betamethasone—psoriasis	0.000178	0.00116	CcSEcCtD
Ticlopidine—Haemoglobin—Dexamethasone—psoriasis	0.000178	0.00116	CcSEcCtD
Ticlopidine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000178	0.00251	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—TNF—psoriasis	0.000178	0.00251	CbGpPWpGaD
Ticlopidine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000177	0.00251	CbGpPWpGaD
Ticlopidine—Haemorrhage—Dexamethasone—psoriasis	0.000177	0.00115	CcSEcCtD
Ticlopidine—Haemorrhage—Betamethasone—psoriasis	0.000177	0.00115	CcSEcCtD
Ticlopidine—MPO—Vitamin B12 Metabolism—IL6—psoriasis	0.000176	0.00249	CbGpPWpGaD
Ticlopidine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000175	0.00248	CbGpPWpGaD
Ticlopidine—Asthenia—Hydroxyurea—psoriasis	0.000175	0.00114	CcSEcCtD
Ticlopidine—Pain—Mycophenolic acid—psoriasis	0.000175	0.00114	CcSEcCtD
Ticlopidine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000175	0.00247	CbGpPWpGaD
Ticlopidine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000174	0.00245	CbGpPWpGaD
Ticlopidine—Myalgia—Cyclosporine—psoriasis	0.000173	0.00113	CcSEcCtD
Ticlopidine—Arthralgia—Cyclosporine—psoriasis	0.000173	0.00113	CcSEcCtD
Ticlopidine—Liver function test abnormal—Methotrexate—psoriasis	0.000172	0.00112	CcSEcCtD
Ticlopidine—Angioedema—Prednisolone—psoriasis	0.000169	0.0011	CcSEcCtD
Ticlopidine—Myalgia—Mycophenolate mofetil—psoriasis	0.000169	0.0011	CcSEcCtD
Ticlopidine—Arthralgia—Mycophenolate mofetil—psoriasis	0.000169	0.0011	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Prednisone—psoriasis	0.000168	0.0011	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000167	0.00109	CcSEcCtD
Ticlopidine—Diarrhoea—Hydroxyurea—psoriasis	0.000167	0.00109	CcSEcCtD
Ticlopidine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000166	0.00234	CbGpPWpGaD
Ticlopidine—Anaphylactic shock—Cyclosporine—psoriasis	0.000166	0.00108	CcSEcCtD
Ticlopidine—Angioedema—Hydrocortisone—psoriasis	0.000165	0.00107	CcSEcCtD
Ticlopidine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000164	0.00232	CbGpPWpGaD
Ticlopidine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000164	0.00231	CbGpPWpGaD
Ticlopidine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000162	0.00229	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Cyclosporine—psoriasis	0.000162	0.00106	CcSEcCtD
Ticlopidine—Body temperature increased—Mycophenolic acid—psoriasis	0.000162	0.00105	CcSEcCtD
Ticlopidine—Dizziness—Hydroxyurea—psoriasis	0.000162	0.00105	CcSEcCtD
Ticlopidine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000162	0.00105	CcSEcCtD
Ticlopidine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000161	0.00227	CbGpPWpGaD
Ticlopidine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.00016	0.00226	CbGpPWpGaD
Ticlopidine—Eosinophilia—Methotrexate—psoriasis	0.000159	0.00104	CcSEcCtD
Ticlopidine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000158	0.00103	CcSEcCtD
Ticlopidine—Anorexia—Cyclosporine—psoriasis	0.000158	0.00103	CcSEcCtD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000157	0.00221	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—TP53—psoriasis	0.000157	0.00221	CbGpPWpGaD
Ticlopidine—Vomiting—Hydroxyurea—psoriasis	0.000155	0.00101	CcSEcCtD
Ticlopidine—Angioedema—Triamcinolone—psoriasis	0.000155	0.00101	CcSEcCtD
Ticlopidine—Haemoglobin—Prednisone—psoriasis	0.000155	0.00101	CcSEcCtD
Ticlopidine—Haemorrhage—Prednisone—psoriasis	0.000154	0.001	CcSEcCtD
Ticlopidine—Rash—Hydroxyurea—psoriasis	0.000154	0.001	CcSEcCtD
Ticlopidine—Anorexia—Mycophenolate mofetil—psoriasis	0.000154	0.001	CcSEcCtD
Ticlopidine—Dermatitis—Hydroxyurea—psoriasis	0.000154	0.001	CcSEcCtD
Ticlopidine—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000154	0.00217	CbGpPWpGaD
Ticlopidine—Myalgia—Hydrocortisone—psoriasis	0.000154	0.001	CcSEcCtD
Ticlopidine—Headache—Hydroxyurea—psoriasis	0.000153	0.000998	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—psoriasis	0.000153	0.000996	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000151	0.000984	CcSEcCtD
Ticlopidine—Anaphylactic shock—Prednisolone—psoriasis	0.000151	0.000982	CcSEcCtD
Ticlopidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000151	0.00213	CbGpPWpGaD
Ticlopidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00015	0.00212	CbGpPWpGaD
Ticlopidine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000147	0.000959	CcSEcCtD
Ticlopidine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000147	0.000959	CcSEcCtD
Ticlopidine—Asthenia—Mycophenolic acid—psoriasis	0.000147	0.000957	CcSEcCtD
Ticlopidine—Dyspepsia—Cyclosporine—psoriasis	0.000146	0.00095	CcSEcCtD
Ticlopidine—Nausea—Hydroxyurea—psoriasis	0.000145	0.000946	CcSEcCtD
Ticlopidine—Pruritus—Mycophenolic acid—psoriasis	0.000145	0.000944	CcSEcCtD
Ticlopidine—Myalgia—Triamcinolone—psoriasis	0.000145	0.000942	CcSEcCtD
Ticlopidine—Decreased appetite—Cyclosporine—psoriasis	0.000144	0.000938	CcSEcCtD
Ticlopidine—MPO—Folate Metabolism—IL6—psoriasis	0.000143	0.00202	CbGpPWpGaD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000142	0.000927	CcSEcCtD
Ticlopidine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000142	0.000927	CcSEcCtD
Ticlopidine—Pain—Cyclosporine—psoriasis	0.000142	0.000923	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—psoriasis	0.000141	0.00092	CcSEcCtD
Ticlopidine—MPO—Selenium Micronutrient Network—TNF—psoriasis	0.000141	0.00199	CbGpPWpGaD
Ticlopidine—Angioedema—Betamethasone—psoriasis	0.000141	0.000918	CcSEcCtD
Ticlopidine—Angioedema—Dexamethasone—psoriasis	0.000141	0.000918	CcSEcCtD
Ticlopidine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.00014	0.00198	CbGpPWpGaD
Ticlopidine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00014	0.000915	CcSEcCtD
Ticlopidine—Anorexia—Hydrocortisone—psoriasis	0.00014	0.000915	CcSEcCtD
Ticlopidine—Diarrhoea—Mycophenolic acid—psoriasis	0.00014	0.000913	CcSEcCtD
Ticlopidine—Anaphylactic shock—Triamcinolone—psoriasis	0.000139	0.000903	CcSEcCtD
Ticlopidine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000139	0.00196	CbGpPWpGaD
Ticlopidine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000138	0.00195	CbGpPWpGaD
Ticlopidine—Pain—Mycophenolate mofetil—psoriasis	0.000138	0.000901	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—psoriasis	0.000137	0.000892	CcSEcCtD
Ticlopidine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000136	0.00192	CbGpPWpGaD
Ticlopidine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000135	0.000883	CcSEcCtD
Ticlopidine—Dizziness—Mycophenolic acid—psoriasis	0.000135	0.000882	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—psoriasis	0.000135	0.000882	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000134	0.000874	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000132	0.000861	CcSEcCtD
Ticlopidine—Urticaria—Cyclosporine—psoriasis	0.000132	0.000858	CcSEcCtD
Ticlopidine—Myalgia—Dexamethasone—psoriasis	0.000131	0.000855	CcSEcCtD
Ticlopidine—Myalgia—Betamethasone—psoriasis	0.000131	0.000855	CcSEcCtD
Ticlopidine—Body temperature increased—Cyclosporine—psoriasis	0.000131	0.000853	CcSEcCtD
Ticlopidine—Vomiting—Mycophenolic acid—psoriasis	0.00013	0.000848	CcSEcCtD
Ticlopidine—Dyspepsia—Hydrocortisone—psoriasis	0.00013	0.000845	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—psoriasis	0.000129	0.000844	CcSEcCtD
Ticlopidine—Rash—Mycophenolic acid—psoriasis	0.000129	0.000841	CcSEcCtD
Ticlopidine—Dermatitis—Mycophenolic acid—psoriasis	0.000129	0.000841	CcSEcCtD
Ticlopidine—Pain—Prednisolone—psoriasis	0.000129	0.00084	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—psoriasis	0.000129	0.00084	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—psoriasis	0.000129	0.00084	CcSEcCtD
Ticlopidine—Urticaria—Mycophenolate mofetil—psoriasis	0.000128	0.000837	CcSEcCtD
Ticlopidine—Headache—Mycophenolic acid—psoriasis	0.000128	0.000836	CcSEcCtD
Ticlopidine—P2RY12—Signaling Pathways—HCAR2—psoriasis	0.000128	0.00181	CbGpPWpGaD
Ticlopidine—Decreased appetite—Hydrocortisone—psoriasis	0.000128	0.000834	CcSEcCtD
Ticlopidine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000128	0.000833	CcSEcCtD
Ticlopidine—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000127	0.00179	CbGpPWpGaD
Ticlopidine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000126	0.000823	CcSEcCtD
Ticlopidine—Pain—Hydrocortisone—psoriasis	0.000126	0.00082	CcSEcCtD
Ticlopidine—Anaphylactic shock—Betamethasone—psoriasis	0.000126	0.00082	CcSEcCtD
Ticlopidine—Anaphylactic shock—Dexamethasone—psoriasis	0.000126	0.00082	CcSEcCtD
Ticlopidine—P2RY12—GPCR downstream signaling—CCL20—psoriasis	0.000124	0.00175	CbGpPWpGaD
Ticlopidine—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.000124	0.00175	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Dexamethasone—psoriasis	0.000123	0.000803	CcSEcCtD
Ticlopidine—Thrombocytopenia—Betamethasone—psoriasis	0.000123	0.000803	CcSEcCtD
Ticlopidine—Angioedema—Prednisone—psoriasis	0.000123	0.000799	CcSEcCtD
Ticlopidine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000122	0.00173	CbGpPWpGaD
Ticlopidine—Hypersensitivity—Cyclosporine—psoriasis	0.000122	0.000795	CcSEcCtD
Ticlopidine—Dyspepsia—Triamcinolone—psoriasis	0.000122	0.000795	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—psoriasis	0.000122	0.000794	CcSEcCtD
Ticlopidine—Nausea—Mycophenolic acid—psoriasis	0.000122	0.000793	CcSEcCtD
Ticlopidine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000121	0.00171	CbGpPWpGaD
Ticlopidine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00012	0.000785	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—psoriasis	0.00012	0.000783	CcSEcCtD
Ticlopidine—Anorexia—Dexamethasone—psoriasis	0.00012	0.000781	CcSEcCtD
Ticlopidine—Anorexia—Betamethasone—psoriasis	0.00012	0.000781	CcSEcCtD
Ticlopidine—Urticaria—Prednisolone—psoriasis	0.00012	0.00078	CcSEcCtD
Ticlopidine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000119	0.000776	CcSEcCtD
Ticlopidine—Asthenia—Cyclosporine—psoriasis	0.000119	0.000775	CcSEcCtD
Ticlopidine—Pain—Triamcinolone—psoriasis	0.000119	0.000773	CcSEcCtD
Ticlopidine—Pruritus—Cyclosporine—psoriasis	0.000117	0.000764	CcSEcCtD
Ticlopidine—Urticaria—Hydrocortisone—psoriasis	0.000117	0.000762	CcSEcCtD
Ticlopidine—Body temperature increased—Hydrocortisone—psoriasis	0.000116	0.000758	CcSEcCtD
Ticlopidine—Asthenia—Mycophenolate mofetil—psoriasis	0.000116	0.000756	CcSEcCtD
Ticlopidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000116	0.00163	CbGpPWpGaD
Ticlopidine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000115	0.000747	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000115	0.000747	CcSEcCtD
Ticlopidine—Pruritus—Mycophenolate mofetil—psoriasis	0.000114	0.000745	CcSEcCtD
Ticlopidine—Arthralgia—Prednisone—psoriasis	0.000114	0.000745	CcSEcCtD
Ticlopidine—Myalgia—Prednisone—psoriasis	0.000114	0.000745	CcSEcCtD
Ticlopidine—MPO—Selenium Micronutrient Network—IL6—psoriasis	0.000114	0.00161	CbGpPWpGaD
Ticlopidine—Diarrhoea—Cyclosporine—psoriasis	0.000113	0.000739	CcSEcCtD
Ticlopidine—P2RY12—Signaling by GPCR—CCL20—psoriasis	0.000113	0.00159	CbGpPWpGaD
Ticlopidine—Hypersensitivity—Prednisolone—psoriasis	0.000111	0.000724	CcSEcCtD
Ticlopidine—P2RY12—Signaling Pathways—TAGAP—psoriasis	0.000111	0.00157	CbGpPWpGaD
Ticlopidine—Dyspepsia—Betamethasone—psoriasis	0.000111	0.000722	CcSEcCtD
Ticlopidine—Dyspepsia—Dexamethasone—psoriasis	0.000111	0.000722	CcSEcCtD
Ticlopidine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000111	0.000721	CcSEcCtD
Ticlopidine—Urticaria—Triamcinolone—psoriasis	0.00011	0.000718	CcSEcCtD
Ticlopidine—Body temperature increased—Triamcinolone—psoriasis	0.00011	0.000714	CcSEcCtD
Ticlopidine—Dizziness—Cyclosporine—psoriasis	0.00011	0.000714	CcSEcCtD
Ticlopidine—Anaphylactic shock—Prednisone—psoriasis	0.00011	0.000714	CcSEcCtD
Ticlopidine—Decreased appetite—Dexamethasone—psoriasis	0.000109	0.000713	CcSEcCtD
Ticlopidine—Decreased appetite—Betamethasone—psoriasis	0.000109	0.000713	CcSEcCtD
Ticlopidine—Hypersensitivity—Hydrocortisone—psoriasis	0.000108	0.000707	CcSEcCtD
Ticlopidine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000108	0.00153	CbGpPWpGaD
Ticlopidine—Pain—Dexamethasone—psoriasis	0.000108	0.000701	CcSEcCtD
Ticlopidine—Pain—Betamethasone—psoriasis	0.000108	0.000701	CcSEcCtD
Ticlopidine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000107	0.00151	CbGpPWpGaD
Ticlopidine—Dizziness—Mycophenolate mofetil—psoriasis	0.000107	0.000696	CcSEcCtD
Ticlopidine—Asthenia—Hydrocortisone—psoriasis	0.000106	0.000688	CcSEcCtD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000106	0.00149	CbGpPWpGaD
Ticlopidine—Vomiting—Cyclosporine—psoriasis	0.000105	0.000686	CcSEcCtD
Ticlopidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000104	0.00148	CbGpPWpGaD
Ticlopidine—Rash—Cyclosporine—psoriasis	0.000104	0.000681	CcSEcCtD
Ticlopidine—Anorexia—Prednisone—psoriasis	0.000104	0.00068	CcSEcCtD
Ticlopidine—Dermatitis—Cyclosporine—psoriasis	0.000104	0.00068	CcSEcCtD
Ticlopidine—Pruritus—Hydrocortisone—psoriasis	0.000104	0.000679	CcSEcCtD
Ticlopidine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000104	0.00147	CbGpPWpGaD
Ticlopidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000104	0.00147	CbGpPWpGaD
Ticlopidine—Headache—Cyclosporine—psoriasis	0.000104	0.000676	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000103	0.00067	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Betamethasone—psoriasis	0.000103	0.00067	CcSEcCtD
Ticlopidine—Vomiting—Mycophenolate mofetil—psoriasis	0.000103	0.00067	CcSEcCtD
Ticlopidine—Hypersensitivity—Triamcinolone—psoriasis	0.000102	0.000666	CcSEcCtD
Ticlopidine—Rash—Mycophenolate mofetil—psoriasis	0.000102	0.000664	CcSEcCtD
Ticlopidine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000102	0.000663	CcSEcCtD
Ticlopidine—Headache—Mycophenolate mofetil—psoriasis	0.000101	0.00066	CcSEcCtD
Ticlopidine—Diarrhoea—Hydrocortisone—psoriasis	0.000101	0.000656	CcSEcCtD
Ticlopidine—Urticaria—Betamethasone—psoriasis	9.99e-05	0.000651	CcSEcCtD
Ticlopidine—Urticaria—Dexamethasone—psoriasis	9.99e-05	0.000651	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Prednisone—psoriasis	9.98e-05	0.00065	CcSEcCtD
Ticlopidine—Dizziness—Prednisolone—psoriasis	9.97e-05	0.00065	CcSEcCtD
Ticlopidine—Asthenia—Triamcinolone—psoriasis	9.94e-05	0.000648	CcSEcCtD
Ticlopidine—Body temperature increased—Dexamethasone—psoriasis	9.94e-05	0.000648	CcSEcCtD
Ticlopidine—Body temperature increased—Betamethasone—psoriasis	9.94e-05	0.000648	CcSEcCtD
Ticlopidine—Nausea—Cyclosporine—psoriasis	9.84e-05	0.000641	CcSEcCtD
Ticlopidine—Pruritus—Triamcinolone—psoriasis	9.8e-05	0.000639	CcSEcCtD
Ticlopidine—P2RY12—G alpha (i) signalling events—CXCL8—psoriasis	9.78e-05	0.00138	CbGpPWpGaD
Ticlopidine—Dizziness—Hydrocortisone—psoriasis	9.73e-05	0.000634	CcSEcCtD
Ticlopidine—Dyspepsia—Prednisone—psoriasis	9.64e-05	0.000628	CcSEcCtD
Ticlopidine—Nausea—Mycophenolate mofetil—psoriasis	9.6e-05	0.000626	CcSEcCtD
Ticlopidine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	9.56e-05	0.00135	CbGpPWpGaD
Ticlopidine—Myalgia—Methotrexate—psoriasis	9.55e-05	0.000622	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—psoriasis	9.55e-05	0.000622	CcSEcCtD
Ticlopidine—Decreased appetite—Prednisone—psoriasis	9.52e-05	0.000621	CcSEcCtD
Ticlopidine—Rash—Prednisolone—psoriasis	9.5e-05	0.000619	CcSEcCtD
Ticlopidine—Dermatitis—Prednisolone—psoriasis	9.49e-05	0.000619	CcSEcCtD
Ticlopidine—Headache—Prednisolone—psoriasis	9.44e-05	0.000615	CcSEcCtD
Ticlopidine—Vomiting—Hydrocortisone—psoriasis	9.36e-05	0.00061	CcSEcCtD
Ticlopidine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	9.35e-05	0.00132	CbGpPWpGaD
Ticlopidine—Rash—Hydrocortisone—psoriasis	9.28e-05	0.000605	CcSEcCtD
Ticlopidine—Dermatitis—Hydrocortisone—psoriasis	9.27e-05	0.000604	CcSEcCtD
Ticlopidine—Headache—Hydrocortisone—psoriasis	9.22e-05	0.000601	CcSEcCtD
Ticlopidine—Dizziness—Triamcinolone—psoriasis	9.16e-05	0.000597	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—psoriasis	9.15e-05	0.000597	CcSEcCtD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	9.13e-05	0.00129	CbGpPWpGaD
Ticlopidine—Asthenia—Dexamethasone—psoriasis	9.02e-05	0.000588	CcSEcCtD
Ticlopidine—Asthenia—Betamethasone—psoriasis	9.02e-05	0.000588	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—psoriasis	8.96e-05	0.000584	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Prednisone—psoriasis	8.95e-05	0.000584	CcSEcCtD
Ticlopidine—Nausea—Prednisolone—psoriasis	8.95e-05	0.000584	CcSEcCtD
Ticlopidine—Pruritus—Betamethasone—psoriasis	8.9e-05	0.00058	CcSEcCtD
Ticlopidine—Pruritus—Dexamethasone—psoriasis	8.9e-05	0.00058	CcSEcCtD
Ticlopidine—Vomiting—Triamcinolone—psoriasis	8.81e-05	0.000574	CcSEcCtD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	8.78e-05	0.00124	CbGpPWpGaD
Ticlopidine—Nausea—Hydrocortisone—psoriasis	8.74e-05	0.00057	CcSEcCtD
Ticlopidine—Rash—Triamcinolone—psoriasis	8.74e-05	0.00057	CcSEcCtD
Ticlopidine—Dermatitis—Triamcinolone—psoriasis	8.73e-05	0.000569	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—psoriasis	8.72e-05	0.000569	CcSEcCtD
Ticlopidine—Urticaria—Prednisone—psoriasis	8.7e-05	0.000567	CcSEcCtD
Ticlopidine—Headache—Triamcinolone—psoriasis	8.68e-05	0.000566	CcSEcCtD
Ticlopidine—Body temperature increased—Prednisone—psoriasis	8.66e-05	0.000564	CcSEcCtD
Ticlopidine—Diarrhoea—Betamethasone—psoriasis	8.6e-05	0.000561	CcSEcCtD
Ticlopidine—Diarrhoea—Dexamethasone—psoriasis	8.6e-05	0.000561	CcSEcCtD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—VEGFA—psoriasis	8.34e-05	0.00118	CbGpPWpGaD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—psoriasis	8.34e-05	0.000544	CcSEcCtD
Ticlopidine—Dizziness—Betamethasone—psoriasis	8.32e-05	0.000542	CcSEcCtD
Ticlopidine—Dizziness—Dexamethasone—psoriasis	8.32e-05	0.000542	CcSEcCtD
Ticlopidine—Nausea—Triamcinolone—psoriasis	8.23e-05	0.000537	CcSEcCtD
Ticlopidine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	8.1e-05	0.00114	CbGpPWpGaD
Ticlopidine—Hypersensitivity—Prednisone—psoriasis	8.07e-05	0.000526	CcSEcCtD
Ticlopidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.06e-05	0.00114	CbGpPWpGaD
Ticlopidine—Dyspepsia—Methotrexate—psoriasis	8.06e-05	0.000525	CcSEcCtD
Ticlopidine—Vomiting—Dexamethasone—psoriasis	8e-05	0.000521	CcSEcCtD
Ticlopidine—Vomiting—Betamethasone—psoriasis	8e-05	0.000521	CcSEcCtD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	7.97e-05	0.00113	CbGpPWpGaD
Ticlopidine—Decreased appetite—Methotrexate—psoriasis	7.96e-05	0.000519	CcSEcCtD
Ticlopidine—Rash—Betamethasone—psoriasis	7.93e-05	0.000517	CcSEcCtD
Ticlopidine—Rash—Dexamethasone—psoriasis	7.93e-05	0.000517	CcSEcCtD
Ticlopidine—Dermatitis—Dexamethasone—psoriasis	7.92e-05	0.000516	CcSEcCtD
Ticlopidine—Dermatitis—Betamethasone—psoriasis	7.92e-05	0.000516	CcSEcCtD
Ticlopidine—Headache—Dexamethasone—psoriasis	7.88e-05	0.000514	CcSEcCtD
Ticlopidine—Headache—Betamethasone—psoriasis	7.88e-05	0.000514	CcSEcCtD
Ticlopidine—Asthenia—Prednisone—psoriasis	7.86e-05	0.000512	CcSEcCtD
Ticlopidine—Pain—Methotrexate—psoriasis	7.83e-05	0.00051	CcSEcCtD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	7.77e-05	0.0011	CbGpPWpGaD
Ticlopidine—Pruritus—Prednisone—psoriasis	7.75e-05	0.000505	CcSEcCtD
Ticlopidine—Diarrhoea—Prednisone—psoriasis	7.49e-05	0.000488	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—psoriasis	7.48e-05	0.000488	CcSEcCtD
Ticlopidine—Nausea—Dexamethasone—psoriasis	7.47e-05	0.000487	CcSEcCtD
Ticlopidine—Nausea—Betamethasone—psoriasis	7.47e-05	0.000487	CcSEcCtD
Ticlopidine—P2RY12—Hemostasis—NOS2—psoriasis	7.42e-05	0.00105	CbGpPWpGaD
Ticlopidine—Urticaria—Methotrexate—psoriasis	7.27e-05	0.000474	CcSEcCtD
Ticlopidine—Dizziness—Prednisone—psoriasis	7.24e-05	0.000472	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—psoriasis	7.23e-05	0.000472	CcSEcCtD
Ticlopidine—Vomiting—Prednisone—psoriasis	6.96e-05	0.000454	CcSEcCtD
Ticlopidine—Rash—Prednisone—psoriasis	6.9e-05	0.00045	CcSEcCtD
Ticlopidine—Dermatitis—Prednisone—psoriasis	6.9e-05	0.00045	CcSEcCtD
Ticlopidine—Headache—Prednisone—psoriasis	6.86e-05	0.000447	CcSEcCtD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	6.83e-05	0.000965	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	6.83e-05	0.000965	CbGpPWpGaD
Ticlopidine—Hypersensitivity—Methotrexate—psoriasis	6.74e-05	0.00044	CcSEcCtD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.73e-05	0.00095	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCL20—psoriasis	6.65e-05	0.000938	CbGpPWpGaD
Ticlopidine—Asthenia—Methotrexate—psoriasis	6.57e-05	0.000428	CcSEcCtD
Ticlopidine—Nausea—Prednisone—psoriasis	6.5e-05	0.000424	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—psoriasis	6.48e-05	0.000422	CcSEcCtD
Ticlopidine—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	6.41e-05	0.000904	CbGpPWpGaD
Ticlopidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	6.27e-05	0.000885	CbGpPWpGaD
Ticlopidine—Diarrhoea—Methotrexate—psoriasis	6.26e-05	0.000408	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—psoriasis	6.05e-05	0.000395	CcSEcCtD
Ticlopidine—P2RY12—GPCR ligand binding—CXCL8—psoriasis	5.92e-05	0.000836	CbGpPWpGaD
Ticlopidine—Vomiting—Methotrexate—psoriasis	5.82e-05	0.000379	CcSEcCtD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.82e-05	0.000822	CbGpPWpGaD
Ticlopidine—Rash—Methotrexate—psoriasis	5.77e-05	0.000376	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—psoriasis	5.77e-05	0.000376	CcSEcCtD
Ticlopidine—Headache—Methotrexate—psoriasis	5.73e-05	0.000374	CcSEcCtD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.6e-05	0.000791	CbGpPWpGaD
Ticlopidine—Nausea—Methotrexate—psoriasis	5.44e-05	0.000354	CcSEcCtD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.08e-05	0.000718	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NDUFA5—psoriasis	4.8e-05	0.000678	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NDUFA5—psoriasis	4.7e-05	0.000664	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NDUFA5—psoriasis	4.43e-05	0.000626	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.36e-05	0.000615	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.36e-05	0.000615	CbGpPWpGaD
Ticlopidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	4.32e-05	0.00061	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—VEGFA—psoriasis	4.3e-05	0.000607	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.13e-05	0.000583	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP2S1—psoriasis	4.08e-05	0.000576	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NDUFA5—psoriasis	4.06e-05	0.000574	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP2S1—psoriasis	4e-05	0.000564	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.79e-05	0.000535	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP2S1—psoriasis	3.77e-05	0.000532	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SOCS1—psoriasis	3.66e-05	0.000517	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NDUFA5—psoriasis	3.63e-05	0.000512	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—TYK2—psoriasis	3.49e-05	0.000493	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP2S1—psoriasis	3.45e-05	0.000488	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.38e-05	0.000477	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CXCL8—psoriasis	3.35e-05	0.000472	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NDUFA5—psoriasis	3.34e-05	0.000471	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NDUFA5—psoriasis	3.31e-05	0.000467	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—TP53—psoriasis	3.25e-05	0.000459	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP2S1—psoriasis	3.08e-05	0.000435	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.08e-05	0.000435	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CXCL8—psoriasis	3.04e-05	0.000429	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.84e-05	0.0004	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NDUFA5—psoriasis	2.83e-05	0.000399	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP2S1—psoriasis	2.81e-05	0.000397	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—APOE—psoriasis	2.7e-05	0.000381	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—LEP—psoriasis	2.7e-05	0.000381	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.63e-05	0.000372	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NFKBIA—psoriasis	2.52e-05	0.000355	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP2S1—psoriasis	2.4e-05	0.000339	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.18e-05	0.000308	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TYK2—psoriasis	2.06e-05	0.000291	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CARM1—psoriasis	1.99e-05	0.000281	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.97e-05	0.000279	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CARM1—psoriasis	1.95e-05	0.000276	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.85e-05	0.000262	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CARM1—psoriasis	1.84e-05	0.00026	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.81e-05	0.000256	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCL8—psoriasis	1.79e-05	0.000253	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.72e-05	0.000243	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL6—psoriasis	1.71e-05	0.000241	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CARM1—psoriasis	1.69e-05	0.000238	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—JUN—psoriasis	1.67e-05	0.000236	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.62e-05	0.000228	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NFKB1—psoriasis	1.61e-05	0.000227	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.58e-05	0.000223	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CARM1—psoriasis	1.51e-05	0.000213	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.47e-05	0.000208	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—psoriasis	1.46e-05	0.000206	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—psoriasis	1.44e-05	0.000204	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.41e-05	0.000199	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CARM1—psoriasis	1.39e-05	0.000196	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CARM1—psoriasis	1.37e-05	0.000194	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.28e-05	0.000181	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.26e-05	0.000178	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CAT—psoriasis	1.23e-05	0.000173	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CAT—psoriasis	1.2e-05	0.00017	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CARM1—psoriasis	1.17e-05	0.000166	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CAT—psoriasis	1.13e-05	0.00016	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—psoriasis	1.1e-05	0.000156	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.1e-05	0.000155	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CAT—psoriasis	1.04e-05	0.000147	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—psoriasis	1.01e-05	0.000142	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—APOE—psoriasis	9.52e-06	0.000134	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—APOE—psoriasis	9.33e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CAT—psoriasis	9.26e-06	0.000131	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CARM1—psoriasis	9.06e-06	0.000128	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—APOE—psoriasis	8.79e-06	0.000124	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CAT—psoriasis	8.52e-06	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CAT—psoriasis	8.45e-06	0.000119	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPARG—psoriasis	8.3e-06	0.000117	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPARG—psoriasis	8.13e-06	0.000115	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—APOE—psoriasis	8.06e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPARG—psoriasis	7.66e-06	0.000108	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CAT—psoriasis	7.22e-06	0.000102	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—APOE—psoriasis	7.2e-06	0.000102	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPARG—psoriasis	7.02e-06	9.92e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—APOE—psoriasis	6.62e-06	9.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—APOE—psoriasis	6.56e-06	9.27e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPARG—psoriasis	6.27e-06	8.85e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPARG—psoriasis	5.77e-06	8.14e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPARG—psoriasis	5.72e-06	8.07e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—APOE—psoriasis	5.61e-06	7.92e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CAT—psoriasis	5.57e-06	7.86e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPARG—psoriasis	4.88e-06	6.9e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—APOE—psoriasis	4.33e-06	6.11e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPARG—psoriasis	3.77e-06	5.32e-05	CbGpPWpGaD
